EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Chemical Probes Portal—2026: expanding and enhancing this expert review-based public resource to sustain chemical probe selection and application in bioscience

Muge Sarper iD, Domenico Sanfelice iD, Yi Chen iD, Rezvan Chitsazi iD, Phillip W Gingrich iD, Albert A Antolin iD, Benjamin Bellenie iD, Paul E Brennan iD, Aled Edwards iD, Susanne Müller iD, Bissan Al-Lazikani iD, Paul Workman iD

Nucleic Acids Research · 12.11.2026

DOI: 10.1093/nar/gkag1180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.11.2026. Verfasst von Muge Sarper und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, United Kingdom. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome, Diego Megia and Lola Manterola, The Institute of Cancer Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Chemical Probes Portal (https://www.chemicalprobes.org) is an open, international, resource empowering scientific robustness by supporting responsible research using chemical probes. The Portal informs best-practice in the selection and application of small-molecule chemical probes through expert review, manual curation, and community engagement. Used correctly, high-quality chemical probes are powerful, versatile research tools enabling the fundamental study of protein function, target validation, and development of new therapeutics. Conversely, the inappropriate selection and use of these chemical tools can compromise experimental interpretation, reliability, and translational impact, highlighting the need for trusted advisory resources. The Portal addresses this challenge, providing a unique collection of curated data, expert reviews, and related guidance. We describe significant developments to the Portal’s content and infrastructure. We have substantially expanded the content, with curated probes increasing by 26% since our last update. We have significantly enhanced website functionality through implementation of new, more informative probe pages, improved search tools and enhancements in data accessibility, machine readability, and interoperability. Together, these developments strengthen the Portal as a trustworthy, user-friendly provider of expert-reviewed chemical probe information and an increasingly valuable source of gold-standard FAIR, accessible data in the era of AI-assisted information discovery, underpinning reliable bioscience research.

Autor:innen und Institutionen

  • Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, United Kingdom.
  • Chemical Probes Portal, www.chemicalprobes.org.
  • Department of Genomic Medicine and the Institute for Data Science in Oncology, University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, TX 77054, United States.
  • AI-Driven Drug Discovery Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Carrer de Natzaret, 117, 08035 Barcelona, Spain.
  • Centre for Medicines Discovery, Nuffield Department of Medicine, NDM Research Building, University of Oxford, Oxford OX3 7FZ, United Kingdom.
  • Structural Genomics Consortium, MaRS Centre, South Tower, 101 College St., Suite 700, Toronto, ON M5G 1L7, Canada.

ORCID-Profile: Muge Sarper, Domenico Sanfelice, Yi Chen, Rezvan Chitsazi, Phillip W Gingrich, Albert A Antolin, Benjamin Bellenie, Paul E Brennan, Aled Edwards, Susanne Müller, Bissan Al-Lazikani, Paul Workman

Förderung

  • Wellcome
  • Diego Megia and Lola Manterola
  • The Institute of Cancer Research
  • Cancer Prevention and Research Institute of Texas
  • Multi-Investigator Research Award
  • The Lyda Hill Foundation
  • NCI NIH HHS
  • National Institute of Health

Zitieren

APA

Sarper, M., Sanfelice, D., Chen, Y., Chitsazi, R., Gingrich, P. W., Antolin, A. A., Bellenie, B., Brennan, P. E., Edwards, A., Müller, S., Al-Lazikani, B., & Workman, P. (2026). The Chemical Probes Portal—2026: expanding and enhancing this expert review-based public resource to sustain chemical probe selection and application in bioscience. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag1180

Vancouver

Sarper M, Sanfelice D, Chen Y, Chitsazi R, Gingrich PW, Antolin AA, et al. The Chemical Probes Portal—2026: expanding and enhancing this expert review-based public resource to sustain chemical probe selection and application in bioscience. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag1180

BibTeX
@article{Sarper2026,
  author = {Sarper, Muge and Sanfelice, Domenico and Chen, Yi and Chitsazi, Rezvan and Gingrich, Phillip W and Antolin, Albert A and Bellenie, Benjamin and Brennan, Paul E and Edwards, Aled and Müller, Susanne and Al-Lazikani, Bissan and Workman, Paul},
  title = {The Chemical Probes Portal—2026: expanding and enhancing this expert review-based public resource to sustain chemical probe selection and application in bioscience},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkag1180}
}
Kostenlos starten →